New research published in the journal PNAS that was led by investigators at Massachusetts General Hospital (MGH) and the University of Geneva (UNIGE) provides insights into why some types of colorectal cancer don't respond to immune checkpoint inhibitors and offer a strategy to overcome their resistance.
from health-it - Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3mNVbdp
0 Comments